Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 9, 2013, Pages 1243-1244

  Yoo, Jung Wan ^a   Lyu, Jiwon ^a   Lee, Sang Do ^a   Kim, Woo Sung ^a   Kim, Dong Soon ^a   Shim, Tae Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; LINEZOLID; OFLOXACIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; LIVER TOXICITY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN DISCOLORATION; TREATMENT DURATION;

EID: 84883003441     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0312     Document Type: Letter

References (5)

1. Barry V C, Belton J G, Conalty M L, et al. A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature 1957; 179: 1013-1015.
2. Jagannath C, Reddy M V, Kailasam S, O'Sullivan J F, Gangadharam P R. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. Am J Repir Crit Care Med 1995; 151: 1083-1086.
3. Xu H B, Jiang R H, Xiao H P. Clofazimine in the treatment of multidrug-resistant tuberculosis. Clin Microbiol Infect 2012; 18: 1104-1110.
4. Van Deun A, Maug A K J, Salim M A H, et al. Short, highly effective, and inexpensive standardized treatment of multidrugr esistant tuberculosis. Am J Respir Crit Care Med 2010; 182: 684-692.
5. Dey T, Brigden G, Cox H, Shubber Z, Cooke G, Ford N. Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2013; 68: 284-293.